Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending August 28, 2008. The report serves as a notification of transactions involving a Person Discharging Managerial Responsibility (PDMR) in accordance with Disclosure Rule 3.1.4R(1)(a).
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is strictly a disclosure of insider trading activity and does not contain financial performance data.
Material Changes
The material change reported is the sale of American Depositary Receipts (ADRs) by Mr. D J Phelan, a Person Discharging Managerial Responsibility. The transactions occurred on August 25, 2008, and were notified to the company on August 28, 2008.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items beyond the specific insider transaction disclosed.
Important Facts for Investors
- Insider Sale: Mr. D J Phelan sold a total of 11,090 ADR shares on August 25, 2008.
- Transaction Details: 5,000 shares were sold at $46.08 per share, and 6,090 shares were sold at $46.01 per share.
- Notification Date: The company was advised of these transactions on August 28, 2008.
- Document Scope: This filing contains no financial results or strategic updates.